Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Paroxetine hydrochloride hemihydrate
Drug ID BADD_D01681
Description Paroxetine is a selective serotonin reuptake inhibitor (SSRI) drug commonly known as Paxil. It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others.[T653] It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham.[L7712,L7715] A unique feature of this drug is that it is highly potent and selective in its inhibition of serotonin reuptake and has little effect on other neurotransmitters.[A31914] Because of its potent inhibition of serotonin reuptake, paroxetine is more likely to cause withdrawal effects upon cessation. Paroxetine is well tolerated in most patients with a similar adverse effect profile to other members of its drug class.[A31914] The controlled release formulation was designed to decrease the likelihood of nausea that is sometimes associated with paroxetine.[L7700,L7742]
Indications and Usage Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]
Marketing Status approved; investigational
ATC Code N06AB05
DrugBank ID DB00715
KEGG ID D02260
MeSH ID D017374
PubChem ID 9843029
TTD Drug ID D06GDY
NDC Product Code 42858-705; 70518-1253; 71610-243; 42858-707; 63629-9498; 70518-0550; 73377-051; 70518-2376; 43547-348; 55700-503; 63187-927; 70518-2387; 43353-544; 55289-053; 63629-9499; 63629-9500; 0378-7003; 0378-7004; 70518-1406; 53296-0057; 42858-703; 43547-349; 50090-5987; 71205-527; 71610-204; 0615-7985; 62350-0044; 43353-554; 43547-350; 0378-7001; 0378-7002; 70518-2182; 70518-2598; 64220-113; 55289-037; 71205-198; 43547-347
UNII 41VRH5220H
Synonyms Paroxetine | Aropax | BRL-29060 | BRL 29060 | BRL29060 | FG-7051 | FG 7051 | FG7051 | Paroxetine Acetate | Seroxat | Paroxetine Hydrochloride Anhydrous | Paroxetine Maleate | Paroxetine, cis-(+)-Isomer | Paroxetine, cis-(-)-Isomer | Paroxetine, trans-(+)-Isomer | Paxil | Paroxetine Hydrochloride Hemihydrate | Paroxetine Hydrochloride, Hemihydrate | Paroxetine Hydrochloride
Chemical Information
Molecular Formula C19H23ClFNO4
CAS Registry Number 110429-35-1
SMILES C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthma22.03.01.002; 10.01.03.010--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Atrial fibrillation02.03.03.002--
Atrioventricular block02.03.01.002--Not Available
Back pain15.03.04.005--
Basophilia01.02.01.009--Not Available
Bipolar I disorder19.16.01.002--Not Available
Bleeding time prolonged13.01.02.002--Not Available
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Blood creatine phosphokinase increased13.04.01.001--
Blood lactate dehydrogenase increased13.04.02.002--
Blood urea increased13.13.01.006--Not Available
Bradycardia02.03.02.002--Not Available
Bradykinesia17.01.02.004--Not Available
Breast atrophy21.05.04.005--
Breast enlargement21.05.04.001--Not Available
Breast pain21.05.05.003--
Bronchitis22.07.01.001; 11.01.09.001--
Bruxism19.11.03.001; 07.01.06.008--Not Available
Bulimia nervosa19.09.01.006; 14.03.03.001--Not Available
Bundle branch block02.03.01.009--Not Available
Bursitis12.04.03.010; 15.04.01.001--Not Available
Calculus urinary20.04.03.002--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cardiospasm07.02.04.007--Not Available
Cataract06.06.01.001--
Cellulitis23.11.02.004; 11.02.01.001--Not Available
Cerebral ischaemia24.04.06.003; 17.08.01.005--
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 13 Pages